First-in-Class Switch Approvals: Oral Contraceptives and Opioid Overdose Treatment
Much to the delight of American women, oral contraceptives, known as “the pill,” will now be available without a prescription.
JOIN OUR TEAM
Much to the delight of American women, oral contraceptives, known as “the pill,” will now be available without a prescription.
Beauty nutrition products continue to rise in popularity as consumers are exploring new ways to look and feel good, from the inside out. Such products have found homes in all channels of distribution—offline and online—in the United States, and their sales are projected to increase at a CAGR of 9% through 2025, according to our research.
Looking back at the second year of the global pandemic, we’re reflecting on the issues that shaped the consumer healthcare industry while gauging consumers’ top priorities. One of the most notable themes of 2021 was the increased demand for wellness and treatment products, a trend that is expected to continue for the next several years. Fueled by the growing interest in wellness, innovative products are launching in categories focused on immunity and the “beauty from within” market.
The consumer self-care industry is shifting in the wake of the COVID-19 pandemic, with both consumers and retailers focusing on wellness. According to the University of California, Davis, “Wellness is an active process of becoming aware of and making choices toward a healthy and fulfilling life. Wellness is more than being free from illness; it is a dynamic
As the COVID-19 pandemic continues to affect the world’s economies, some consumer healthcare categories are faring better than others. Timely updates from our KlinePULSE Consumer Healthcare Industry Trends: U.S. Annual Subscriptions Service provide research findings on noteworthy category developments. One in-depth report examines the paradigm shift of consumer preference for disease prevention and maintaining wellness as opposed to disease treatment. The trend, which was emerging pre-COVID, has taken on
While prevention and boosting immunity have always been important tools in self–care, since the COVID-19 pandemic started in the United States in March 2020, consumers have wholeheartedly embraced using various vitamins, minerals, herbs, and other products to ward off illness and help support their immune systems. Immune support products can span multiple product types but typically include one or more of the following:
Earlier this month, Sanofi announced a new strategic vision for its Consumer Healthcare division. The new head of the division, Julie Van Ongevalle, shared that the company will focus on core brands and categories while pursuing first-in-class Rx-to-OTC switches in the ED and flu categories in the United States. Key components to future growth of Sanofi’s OTC business in the United
In what is normally a slow–growing category in the 0.5%-3.0% range for year–over–year performance, the internal analgesics category witnessed much stronger–than–average growth rates in 2020. Consumers stocked up on pain relievers and fever reducers to be prepared for coronavirus. The overall internal analgesics category witnessed sales growth of more than 6.0%, with the Tylenol brand up nearly 40% and Motrin
In 2020, the U.S. market saw four new brands previously sold as prescription drugs enter the nonprescription market: Pataday allergy eye drops Voltaren Arthritis Pain topical NSAID Advil Dual Action ibuprofen and acetaminophen pain reliever Sklice lice treatment The new switch approvals have signaled a willingness on the part of regulators to be less conservative when it comes to OTC access
As 2020 concludes, we are reflecting on the priority of health and safety, and how drastically different our everyday lives are compared to just eight months ago. We have seen major shifts toward the importance of immunity, with less emphasis on treatment of symptoms and more focus on prevention. We have a new perspective on the evolving role consumer healthcare products play in keeping us healthy. To help you put these major trends into perspective, below is a summary of our market studies and whitepapers that were
Cookie | Duration | Description |
---|---|---|
cookielawinfo-checkbox-analytics | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics". |
cookielawinfo-checkbox-functional | 11 months | The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional". |
cookielawinfo-checkbox-necessary | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary". |
cookielawinfo-checkbox-others | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other. |
cookielawinfo-checkbox-performance | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance". |
viewed_cookie_policy | 11 months | The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data. |